ArticleNeuro-oncology advances

Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma.

Andrea Schmidts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.